Pregabalin Capsules Recalled Due to Foreign Tablet Contamination During Packaging
Rising Pharma's pregabalin capsules are being recalled nationwide after a pantoprazole tablet was discovered during packaging. No illnesses have been reported.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recall with no reported illnesses or injuries. A single foreign tablet was discovered during packaging quality control. Although the presence of wrong medication in a prescription drug bottle represents a theoretical contamination risk, no adverse events have been reported.
Plain-English summary
Rising Pharma Holdings, Inc. is recalling Pregabalin Capsules (50mg, 1000-count bottle) distributed nationwide due to contamination discovered during repackaging.
During packaging setup, a pantoprazole tablet (20mg) was discovered in a bottle by American Health Packaging, a repackaging firm. The presence of a foreign tablet indicates a contamination event in the manufacturing or repackaging process.
The recall affects pregabalin 50mg capsules, including lot 23132611 with an expiration date of July 31, 2026.
Consumers should inspect their pregabalin bottles for any unusual tablets and contact their pharmacist or healthcare provider if they discover any tablets that do not appear to be pregabalin capsules. Do not take any tablets that look different. Consumers with questions may contact Rising Pharma Holdings, Inc.
The recalled product
- Product
- PREGABALIN (PREGABALIN)
- Brand
- PREGABALIN
- Manufacturer
- Rising Pharma Holding, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 23132611
- Exp 07/31/2026
UPCs (8)
- 0364980413107
- 0364980411103
- 0364980415101
- 0364980412100
- 0364980416108
- 0364980414104
- 0364980410106
- 0364980417105
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PREGABALIN
- ModeratePregabalin Capsules Recalled for Out-of-Specification Manufacturing Defects
FDA (Drugs) · 2022-01-12
- ModerateCardinal Health Recalls Pregabalin Capsules Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
Same manufacturer · Rising Pharma Holding, Inc.
See all →- ModerateCyproheptadine Hydrochloride Syrup Recall Due to Precipitate
FDA (Drugs) · 2026-07-29
- HighTemozolomide capsules recalled after failing impurities and degradation specifications
FDA (Drugs) · 2026-03-11
- HighParkinson's tablets recalled after bottles contained a higher strength tablet
FDA (Drugs) · 2025-10-22
- HighDuloxetine Delayed-Release Capsules Recalled for N-Nitroso Impurity Above Safe Levels
FDA (Drugs) · 2025-03-26
- HighDuloxetine Delayed-Release Capsules recalled for manufacturing deviation and impurity
FDA (Drugs) · 2025-01-15
Same hazard · foreign tablet
See all →- HighAmphetamine salt tablets recalled after bottles contained a lower strength tablet
FDA (Drugs) · 2025-09-17
- HighLisinopril and hydrochlorothiazide bottle contained a foreign antiretroviral tablet
FDA (Drugs) · 2025-07-23
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- HighMetformin ER 500 mg tablets recalled due to foreign tablet contamination
FDA (Drugs) · 2025-01-15
- HighIbuprofen and Famotidine Tablets Recalled for Foreign Tablet Contamination
FDA (Drugs) · 2024-01-24
Similar recalls
- HighFDA recalls Bupropion Hydrochloride tablets for foreign tablet contamination
FDA (Drugs) · 2024-01-17
- ModerateAidapak Recalls Pregabalin Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- HighGabapentin 600 mg Tablets Recalled Due to Metformin Contamination
FDA (Drugs) · 2024-08-14
- ModeratePregabalin Capsules Recalled for Out-of-Specification Manufacturing Defects
FDA (Drugs) · 2022-01-12
- ModeratePregabalin Capsules Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateLupin Recalls Pravastatin Sodium Tablets Due to Foreign Capsule Presence
FDA (Drugs) · 2017-11-29